GE to sell biopharma unit to Danaher for $21.4 billion

General Electric (GE) will sell its biopharma business, which generated $3 billion in revenues for the conglomerate last year, to Danaher in a $21.4 billion deal.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

GE Healthcare files patent lawsuit against Bio-Rad

5 December 2018 American conglomerate GE Healthcare last week filed a lawsuit against California-based life sciences company Bio-Rad Laboratories on four counts of patent infringement.

Americas

GE Healthcare partners with Vanderbilt University to create AI apps

17 January 2019 US-based medical technology company GE Healthcare has entered into a five-year partnership with Vanderbilt University Medical Center to develop cancer immunotherapies using artificial intelligence.

More on this story

Americas

GE Healthcare files patent lawsuit against Bio-Rad

5 December 2018 American conglomerate GE Healthcare last week filed a lawsuit against California-based life sciences company Bio-Rad Laboratories on four counts of patent infringement.

Americas

GE Healthcare partners with Vanderbilt University to create AI apps

More on this story

Americas

GE Healthcare files patent lawsuit against Bio-Rad

5 December 2018 American conglomerate GE Healthcare last week filed a lawsuit against California-based life sciences company Bio-Rad Laboratories on four counts of patent infringement.

Americas

GE Healthcare partners with Vanderbilt University to create AI apps